Corbus Pharmaceuticals (CRBP) Technical (Analysis) Reports Corbus Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Corbus Pharmaceuticals (CRBP)
Technical Analysis Report for NASDAQ stock CRBP Corbus Pharmaceuticals. Dated: 24 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CRBP Corbus Pharmaceuticals then click here. or read Experts views on Corbus Pharmaceuticals or Forecast & share price targets of Corbus Pharmaceuticals
Corbus Pharmaceuticals Opened at 8.17 and Closed at: 8.43, which is 2.85% of previous session's close. It moved within a range of 8.15 and 8.50
The session was a Bullish session with an average volume of 84500, which is -42.6% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
Support for tomorrow is 8.29 and resistance for tomorrow is 8.64
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 8.22, 8.01 resistance for tomorrow's hourly charts is 8.57, 8.71
10 Day SMA for Corbus Pharmaceuticals (CRBP) is 8.69 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Corbus Pharmaceuticals (CRBP) is 9.68 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Corbus Pharmaceuticals (CRBP) is 12.2 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 11.62 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Corbus Pharmaceuticals is 9.5 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Corbus Pharmaceuticals is at 9.68 and 200 DMA is at 9.5, while 50 DMA and 100 DMA are at 12.2 and 11.62 respectively
Corbus Pharmaceuticals (CRBP) moving average of 20 SMA is at 9.68 and 20 EMA is at 9.52
| Date | Closing Price | 20 SMA | 20 EMA |
| 24 Wed Dec | 8.43 | 9.68 | 9.52 |
| 23 Tue Dec | 8.19 | 9.83 | 9.63 |
| 22 Mon Dec | 8.36 | 9.99 | 9.78 |
| 19 Fri Dec | 8.12 | 10.17 | 9.93 |
| 18 Thu Dec | 8.10 | 10.35 | 10.12 |
| 17 Wed Dec | 8.13 | 10.54 | 10.33 |
Corbus Pharmaceuticals (CRBP) moving average of 50 SMA is at 12.2 and 50 EMA is at 10.86
| Date | Closing Price | 50 SMA | 50 EMA |
| 24 Wed Dec | 8.43 | 12.2 | 10.86 |
| 23 Tue Dec | 8.19 | 12.36 | 10.96 |
| 22 Mon Dec | 8.36 | 12.52 | 11.07 |
| 19 Fri Dec | 8.12 | 12.67 | 11.18 |
| 18 Thu Dec | 8.10 | 12.82 | 11.31 |
| 17 Wed Dec | 8.13 | 12.92 | 11.44 |
Corbus Pharmaceuticals (CRBP) moving average of 100 SMA is at 11.62 and 100 EMA is at 11.14
| Date | Closing Price | 100 SMA | 100 EMA |
| 24 Wed Dec | 8.43 | 11.62 | 11.14 |
| 23 Tue Dec | 8.19 | 11.63 | 11.19 |
| 22 Mon Dec | 8.36 | 11.64 | 11.25 |
| 19 Fri Dec | 8.12 | 11.65 | 11.31 |
| 18 Thu Dec | 8.10 | 11.66 | 11.37 |
| 17 Wed Dec | 8.13 | 11.67 | 11.44 |
Corbus Pharmaceuticals (CRBP) moving average of 200 SMA is at 9.5 and 200 EMA is at 13.27
| Date | Closing Price | 200 SMA | 200 EMA |
| 24 Wed Dec | 8.43 | 9.5 | 13.27 |
| 23 Tue Dec | 8.19 | 9.49 | 13.32 |
| 22 Mon Dec | 8.36 | 9.48 | 13.37 |
| 19 Fri Dec | 8.12 | 9.47 | 13.42 |
| 18 Thu Dec | 8.10 | 9.47 | 13.47 |
| 17 Wed Dec | 8.13 | 9.46 | 13.52 |
Sarepta Therapeutics has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Sarepta Therapeutics, about 35.53% more returns!
Soligenix Inc has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Soligenix Inc, about 27% more returns!
Sintx Technologies has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Sintx Technologies, about 20.28% more returns!
Quidel Corporation has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Quidel Corporation, about 34.17% more returns!
Phio Pharmaceuticals has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 14.41% more returns!
Minerva Neurosciences has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Minerva Neurosciences, about 34.07% more returns!
Merus N has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Merus N, about 29.89% more returns!
Inovio Pharmaceuticals has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Inovio Pharmaceuticals, about 43.84% more returns!
Inogen Inc has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Inogen Inc, about 22.72% more returns!
Fulgent Genetics has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Fulgent Genetics, about 18.63% more returns!
Establishment Labs has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Establishment Labs, about 40.27% more returns!
Catalyst Pharmaceuticals has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Catalyst Pharmaceuticals, about 33.39% more returns!
Collegium Pharmaceutical has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Collegium Pharmaceutical, about 36.29% more returns!
Compugen has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Compugen, about 25.9% more returns!
Biotelemetry Inc has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Biotelemetry Inc, about 360.71% more returns!
Arrowhead Pharmaceuticals has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 50.44% more returns!
Allogene Therapeutics has performed better than Corbus Pharmaceuticals in short term. You could have earned much better returns by investing in Allogene Therapeutics, about 27.63% more returns!
Corbus Pharmaceuticals Technical analysis of indicators
Price action analysis of Corbus Pharmaceuticals (CRBP) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Corbus Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Corbus Pharmaceuticals in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Corbus Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Corbus Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Corbus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.35 and Corbus Pharmaceuticals CRBP stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Corbus Pharmaceuticals CRBP stock. Volume based technical analysis of Corbus Pharmaceuticals CRBP stock is negative.
Corbus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock CRBP Corbus Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CRBP Experts View which covers a lot of information including buying and selling signals
CRBP future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Corbus Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Corbus Pharmaceuticals (CRBP) Technical (Analysis) Reports Corbus Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


